Abeona Therapeutics Inc. Stock Forecast NASDAQ:ABEO

Price Target and Analyst Ratings

Most Recent Rating

On July 19, 2021 "HC Wainwright" gave "$8.00 - $5.00" rating for ABEO. The price target was changed from $1.28 to 5.2%.

Last 30 Days

Historical Ratings

Date	Rating	Action	Authority	Current Price	Target Price
2021-07-19	$8.00 - $5.00	Target Lowered by	HC Wainwright	$1.23	$1.28→5.2%
2021-04-14	Buy	Reiterated by	HC Wainwright	$1.60	$8.00
2021-03-29	Buy	Reiterated by	SVB Leerink	$1.79
2021-02-16	Outperform	Reiterated by	SVB Leerink	$2.72
2021-02-16	Buy	Reiterated by	HC Wainwright	$2.72	$8.00
2020-11-25	Buy	Target Lowered by	HC Wainwright	$1.41	$11.00 → $8.00
2020-11-25	Buy	Reiterated by	HC Wainwright	$1.41	$11.00 → $8.00
2020-11-11	Buy	Reiterated by	B. Riley	$1.30	$2.00 → $3.00
2020-11-10	Neutral - Overweight	Upgraded by	Cantor Fitzgerald	$1.15
2020-11-10	Outperform	Target Lowered by	SVB Leerink	$1.15	$8.00 → $5.00
2020-10-06	Buy	Reiterated by	B. Riley	$1.22	$2.00
2020-07-13	Buy	Reiterated by	HC Wainwright	$2.86	$11.00
2020-05-08	Outperform	Target Lowered by	Royal Bank of Canada	$2.69	$11.00 → $7.00

ABEO Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -23.66% during the next 3 months and, with a 90% probability hold a price between $0.77 and $1.01 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.

Data

Date	Bottom	Mid	Top
2021-09-20	$1.00	$1.16	$1.32
2021-09-21	$0.99	$1.15	$1.31
2021-09-22	$0.99	$1.15	$1.31
2021-09-23	$0.98	$1.14	$1.30
2021-09-24	$0.97	$1.13	$1.29
2021-09-27	$0.97	$1.13	$1.29
2021-09-28	$0.96	$1.12	$1.28
2021-09-29	$0.95	$1.11	$1.27
2021-09-30	$0.95	$1.11	$1.27
2021-10-01	$0.94	$1.10	$1.26
2021-10-04	$0.93	$1.09	$1.25
2021-10-05	$0.93	$1.09	$1.25
2021-10-06	$0.92	$1.08	$1.24
2021-10-07	$0.92	$1.07	$1.23
2021-10-08	$0.91	$1.07	$1.23
2021-10-11	$0.90	$1.06	$1.22
2021-10-12	$0.90	$1.05	$1.21
2021-10-13	$0.89	$1.05	$1.21
2021-10-14	$0.88	$1.04	$1.20
2021-10-15	$0.88	$1.04	$1.19
2021-10-18	$0.87	$1.03	$1.19
2021-10-19	$0.86	$1.02	$1.18
2021-10-20	$0.86	$1.02	$1.17
2021-10-21	$0.85	$1.01	$1.17
2021-10-22	$0.84	$1.00	$1.16
2021-10-25	$0.84	$1.00	$1.16
2021-10-26	$0.83	$0.99	$1.15
2021-10-27	$0.82	$0.98	$1.14
2021-10-28	$0.82	$0.98	$1.14
2021-10-29	$0.81	$0.97	$1.13

About Abeona Therapeutics Inc.

Abeona Therapeutics Inc. focuses on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. The companys lead programs are ABO-101 (AAV NAGLU) and ABO-102 (AAV SGSH), adeno-associated virus (AAV)-based gene therapies for Sanfilippo syndrome (MPS IIIB and IIIA). It is also developing ABO-201 (AAV CLN3) gene therapy for juvenile Batten disease (JBD); and ABO-301 (AAV FANCC) for Fanconi anemi... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!